![Christopher Rovaldi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Rovaldi
Plus aucun poste en cours
Profil
Christopher Rovaldi est SVP-Program Management & Operations chez Acceleron Pharma, Inc. M. Rovaldi a précédemment occupé le poste de directeur de la gestion des projets chez Idenix Pharmaceuticals LLC, d'associé de recherche principal chez Periodontix, Inc. et de directeur de la gestion des projets chez Cubist Pharmaceuticals LLC. Il a obtenu un diplôme d'études supérieures et un diplôme de premier cycle de l'Université du New Hampshire.
Anciens postes connus de Christopher Rovaldi
| Sociétés | Poste | Fin |
|---|---|---|
| KEROS THERAPEUTICS, INC. | President | 18/08/2025 |
| ACCELERON PHARMA INC. | Directeur des opérations | 01/05/2018 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2007 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2004 |
Periodontix, Inc.
 Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Corporate Officer/Principal | - |
Formation de Christopher Rovaldi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Commercial Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
